GLP-1 Weight Loss Medications Explained: Who Should Consider Them and Why episode artwork

EPISODE · Nov 11, 2025 · 32 MIN

GLP-1 Weight Loss Medications Explained: Who Should Consider Them and Why

from The Weight Loss Collab

Welcome back to The Weight Loss Collab! In today’s episode, bariatric surgeon and obesity medicine expert Dr. Dovec is diving deep into the world of GLP-1 medications—those popular injectables like Ozempic, Wegovy, Zepbound, and Mounjaro that everyone’s been talking about. Whether you’re fresh out of bariatric surgery, struggling with weight plateaus, have a lower or higher BMI, or you’re just curious if these meds might be right for you, Dr. Dovec breaks down exactly how GLP-1s work, who benefits most, potential side effects, and how to personalize your treatment for the best results. Plus, she compared options like phentermine and Contrave, and gives real talk about surgery versus medication. If you’re looking for up-to-date, honest guidance on weight loss medications and a supportive community cheering you on, this episode is packed with insights and actionable advice!

Episode metadata supplied by the publisher feed · Published Nov 11, 2025

Embed this episode

Ready to play

GLP-1 Weight Loss Medications Explained: Who Should Consider Them and Why

0:00 32:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Weight Loss Collab?

This episode is 32 minutes long.

When was this The Weight Loss Collab episode published?

This episode was published on November 11, 2025.

Can I download this The Weight Loss Collab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!